All Relations between Schizophrenia and Clozapine

Publication Sentence Publish Date Extraction Date Species
H E Shannon, K Rasmussen, F P Bymaster, J C Hart, S C Peters, M D Swedberg, L Jeppesen, M J Sheardown, P Sauerberg, A Fink-Jense. Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophrenia research. vol 42. issue 3. 2000-07-11. PMID:10785583. the present results thus demonstrate that xanomeline has a pharmacologic profile which is similar to that of the atypical antipsychotics clozapine and olanzapine, thus indicating that xanomeline has the potential to be a novel approach in the treatment of psychotic symptoms in patients with schizophrenia. 2000-07-11 2023-08-12 mouse
K Wahlbeck, M Cheine, M A Essal. Clozapine versus typical neuroleptic medication for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796289. clozapine versus typical neuroleptic medication for schizophrenia. 2000-07-06 2023-08-12 Not clear
A Tuunainen, K Wahlbeck, S M Gilbod. Newer atypical antipsychotic medication versus clozapine for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796559. newer atypical antipsychotic medication versus clozapine for schizophrenia. 2000-07-06 2023-08-12 Not clear
J Waserman, M Crioll. Subjective experiences of clozapine treatment by patients with chronic schizophrenia. Psychiatric services (Washington, D.C.). vol 51. issue 5. 2000-06-27. PMID:10783189. subjective experiences of clozapine treatment by patients with chronic schizophrenia. 2000-06-27 2023-08-12 Not clear
M Sajatovic, C R Bingham, D Garver, L F Ramirez, G Ripper, F Blow, L S Lehman. An assessment of clinical practice of clozapine therapy for veterans. Psychiatric services (Washington, D.C.). vol 51. issue 5. 2000-06-27. PMID:10783190. clozapine therapy for 2,996 patients with treatment-refractory schizophrenia was examined over a five-year period in the veterans affairs health care system. 2000-06-27 2023-08-12 Not clear
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Gof. Placebo-controlled trial of glycine added to clozapine in schizophrenia. The American journal of psychiatry. vol 157. issue 5. 2000-05-17. PMID:10784481. placebo-controlled trial of glycine added to clozapine in schizophrenia. 2000-05-17 2023-08-12 Not clear
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Gof. Placebo-controlled trial of glycine added to clozapine in schizophrenia. The American journal of psychiatry. vol 157. issue 5. 2000-05-17. PMID:10784481. the purpose of this study was to evaluate the effects of high-dose oral glycine on positive and negative symptoms and cognitive function when added to clozapine in adults with schizophrenia. 2000-05-17 2023-08-12 Not clear
J Munro, D O'Sullivan, C Andrews, A Arana, A Mortimer, R Kerwi. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. The British journal of psychiatry : the journal of mental science. vol 175. 2000-05-12. PMID:10789357. people prescribed clozapine for treatment-resistant schizophrenia have mandatory haematological monitoring through a case register for identifying reversible neutropenia. 2000-05-12 2023-08-12 Not clear
R Berecz, T Glaub, M Kellermann, A de la Rubia, A Llerena, I Degrel. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient. Pharmacopsychiatry. vol 33. issue 1. 2000-05-10. PMID:10721883. a 30-year-old male patient with paranoid schizophrenia was on clozapine therapy for more than five years. 2000-05-10 2023-08-12 Not clear
S A Chong, G J Remington, N Lee, R Mahendra. Contrasting clozapine prescribing patterns in the east and west? Annals of the Academy of Medicine, Singapore. vol 29. issue 1. 2000-05-04. PMID:10748970. in this survey, we compared the effect of clozapine, an atypical neuroleptic, on polypharmacy in two groups of patients with schizophrenia in two different settings. 2000-05-04 2023-08-12 Not clear
J P Pandarakala. Atypical neuroleptics. Hospital medicine (London, England : 1998). vol 61. issue 1. 2000-04-20. PMID:10735147. the discovery that clozapine alleviates both positive and negative symptoms of schizophrenia has resulted in the emergence of newer atypical neuroleptics. 2000-04-20 2023-08-12 Not clear
N J Brugman, D Cohen, R H de Vrie. [Diabetes mellitus after treatment with clozapine]. Nederlands tijdschrift voor geneeskunde. vol 144. issue 9. 2000-04-05. PMID:10719549. in a 40-year old patient with schizophrenia treated with sustained-action perfenazine for schizophrenia, diabetes mellitus type 2 and hypertension developed when clozapine was added to the regimen. 2000-04-05 2023-08-12 Not clear
V M Rodriguez, M L Catalina, J A García-Noblejas, P Cuest. Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia. Psychiatry research. vol 77. issue 1. 2000-03-31. PMID:10710171. schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia. 2000-03-31 2023-08-12 Not clear
P E Keck, S M Strakowski, S L McElro. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. The Journal of clinical psychiatry. vol 61 Suppl 3. 2000-03-22. PMID:10724127. for this article, the available literature regarding the efficacy of clozapine, risperidone, olanzapine, quetiapine, and ziprasidone in the treatment of depression, hostility, and suicidality in patients with schizophrenia was reviewed. 2000-03-22 2023-08-12 Not clear
P E Keck, S M Strakowski, S L McElro. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. The Journal of clinical psychiatry. vol 61 Suppl 3. 2000-03-22. PMID:10724127. these studies suggest that atypical antipsychotics may exert therapeutic effects on depression and hostility as well as psychosis and that clozapine and olanzapine may reduce suicidality in patients with schizophrenia. 2000-03-22 2023-08-12 Not clear
M Masellis, V S Basile, V Ozdemir, H Y Meltzer, F M Macciardi, J L Kenned. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine. Biological psychiatry. vol 47. issue 3. 2000-03-17. PMID:10682223. the reintroduction of clozapine, the prototype of atypical antipsychotics, in the late 1980s has led to significant advances in the pharmacological management of schizophrenia. 2000-03-17 2023-08-12 Not clear
S V Zimmet, R D Strous, E S Burgess, S Kohnstamm, A I Gree. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of clinical psychopharmacology. vol 20. issue 1. 2000-03-15. PMID:10653215. effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. 2000-03-15 2023-08-12 Not clear
S V Zimmet, R D Strous, E S Burgess, S Kohnstamm, A I Gree. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of clinical psychopharmacology. vol 20. issue 1. 2000-03-15. PMID:10653215. the authors report data from a retrospective survey of substance use in 58 patients treated with clozapine who had a history of comorbid schizophrenia (or schizoaffective disorder) and substance use disorder. 2000-03-15 2023-08-12 Not clear
J A Worrel, P A Marken, S E Beckman, V L Ruehte. Atypical antipsychotic agents: a critical review. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. vol 57. issue 3. 2000-03-09. PMID:10674777. clozapine remains the standard agent for treatment-resistant schizophrenia. 2000-03-09 2023-08-12 Not clear
S A Chong, G J Remington, K Z Bezchlibnyk-Butle. Effect of clozapine on polypharmacy. Psychiatric services (Washington, D.C.). vol 51. issue 2. 2000-03-06. PMID:10655014. prescribing patterns for a group of outpatients with schizophrenia were surveyed for changes after the initiation of clozapine. 2000-03-06 2023-08-12 Not clear